About the Journal
Jurnal Kesehatan Farmasi is a national journal with p-ISSN (2829-3711) and published twice times a year (June and December) since 2019. Jurnal Kesehatan Farmasi is published online by the Pharmacy Department of the Palembang Ministry of Health Polytechnic.
Jurnal Kesehatan Farmasi publishes manuscripts (Original research Article, review articles, and Short communication) on original work, either experimental or theoretical in the following areas: Pharmacology and Toxicology, Pharmacokinetics, Community and Clinical Pharmacy, Pharmaceutical Chemistry, Pharmaceutical Biology, Pharmaceutics, Pharmaceutical Technology, Biopharmaceutics, Pharmaceutical Microbiology and Biotechnology, and Alternative Medicines.
The purpose of publishing the Jurnal Kesehatan Farmasi is to provide scientific information about the development of science and technology in the field of Pharmaceutical Science.
Submission and publication in Jurnal Kesehatan Farmasi is free of charge.
Authors are not allowed to recall submitted manuscripts, as such withdrawals are a waste of valuable resources that editors and referees spend a great deal of time processing submitted manuscripts, and the work invested by the publisher.
If the author still requests a withdrawal of the manuscript while the manuscript is still in the peer-review process, the author will be penalized by paying $35 per manuscript, as a withdrawal penalty to the publisher. However, it is unethical to withdraw a manuscript submitted from one journal if it is received by another.
Withdrawal of manuscripts after the manuscript is accepted for publication, the author will be punished by paying US $ 100 per manuscript. Manuscript withdrawal is only permitted after the withdrawal penalty has been paid in full to the Publisher. If the author does not agree to pay the fine, the author and his affiliates will be blacklisted for publication in this journal. In fact, his previously published articles will be removed from our online system.
If a request for revision of an article submitted to a scientific and health journal is not revised by the author no later than 2 weeks from the date the revision request was sent by the editor, then the article is considered self-admitted for publication in a scientific and health journal and will be subject to a journal withdrawal fee.
Jurnal Kesehatan Farmasi published 2x a year or every 6 months (June and December).
Access of all published manuscripts or articles is free of charge.
- Manuscript which accepted, then will be reviewed by reviewer which competent in their field
- Review policy of Jurnal Kesehatan Farmasi using double blind review
- Notification about accepted or rejected manuscript by online through open journal system (OJS) and will automatically send to author email which registered at registration on website. Therefore, author in registration form must be using active email address and filled the correct email address
The editor of the Jurnal Kesehatan Farmasi is responsible for deciding which of the articles submitted to the journal should be accepted for publication. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editors may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editors may confer with other editors or reviewers in making this decision. The journal used Plagiarism Checker to detect the possibilities of plagiarism in the manuscript.
An editor should evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.
The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
Disclosure and conflicts of interest
- Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.
- Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.
- Editors should recuse themselves (i.e. should ask a co-editor, associate editor or other member of the editorial board instead to review and consider) from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or (possibly) institutions connected to the papers.
- Editors should require all contributors to disclose relevant competing interests and publish corrections if competing interests are revealed after publication. If needed, other appropriate action should be taken, such as the publication of a retraction or expression of concern.
- It should be ensured that the peer-review process for sponsored supplements is the same as that used for the main journal. Items in sponsored supplements should be accepted solely on the basis of academic merit and interest to readers and not be influenced by commercial considerations.
- Non-peer reviewed sections of their journal should be clearly identified.
Involvement and cooperation in investigations
An editor should take reasonably responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper, in conjunction with the publisher (or society). Such measures will generally include contacting the author of the manuscript or paper and giving due consideration of the respective complaint or claims made, but may also include further communications to the relevant institutions and research bodies, and if the complaint is upheld, the publication of a correction, retraction, expression of concern, or other note, as may be relevant. Every reported act of unethical publishing behaviour must be looked into, even if it is discovered years after publication.
DUTIES OF REVIEWERS
Contribution to Editorial Decisions
Reviewer(s) assists the editorial team in making editorial decisions and through the editorial communications with the author. Besides, reviewer(s) may also assist the author in improving the paper.
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.
Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.
Standards of Objectivity
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.
Acknowledgement of Sources
Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
Disclosure and Conflict of Interest
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
DUTIES OF AUTHORS
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical conduct and are unacceptable.
Originality and Plagiarism
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.
Multiple, Redundant or Concurrent Publication
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing conduct and is unacceptable.
Acknowledgement of Sources
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.
Authorship of the Paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
Hazards and Human or Animal Subjects
If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. The procedures related to human or animals should be approved by Ethics Committee and/or refer to the standard procedures.
Natural Medicine Materials
A study using natural medicine materials should provide the latin names, nomenclature author, family name (in parentheses), the source, extraction/fractination methods for all collected materials used in the study. Pharmacological Evaluation of the materials should use a reference (positive control).
Disclosure and Conflicts of Interest
All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.
Fundamental Errors in Published Works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.